Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 8NET 1Gynecologic 1Endocrine 1Classical hematology 1

Conditions

Uterine Cervical Neoplasms 3Ovarian Neoplasms 3Peritoneal Neoplasms 2Endometrial Neoplasms 2Uterine Neoplasms 1Uterine Cervical Dysplasia 1Stomach Neoplasms 1Papillomavirus Infections 1Neoplasms 1Motor Activity 1Lung Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1Colonic Diseases 1Cervical Cancer Screening 1Breast Neoplasms 1

Interventions

pembrolizumab 37Paclitaxel 18Cisplatin 18Carboplatin 14Nivolumab 13Hyperthermic Intraperitoneal Chemotherapy 13Docetaxel 11Cyclophosphamide 11Oxaliplatin 9Irinotecan 9Fluorouracil 9atezolizumab 8Trastuzumab 8Leucovorin 8Bevacizumab 8fludarabine 7Magnetic Resonance Spectroscopy 7Specimen Handling 6Ipilimumab 6Gemcitabine 6Mitomycin 5Cytoreduction Surgical Procedures 5Capecitabine 5durvalumab 4cemiplimab 4aldesleukin 4Taxes 4Psychiatric Rehabilitation 4Platinum 4Drug Therapy 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Stomach Neoplasms × Control Groups × Gynecologic × Clear all
NCT06784765 2025-05-09

Preventive Use of PIPAC in Locally Advanced Gastric Cancer.

National Research Oncology and Transplantology Center, Kazakhstan

Phase NA Recruiting
160 enrolled
GastrointestinalGynecologic

Peritoneal Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡